ResearcherMayo ClinicActive in the last 2 years
Alicia K. Fleming Martinez
Matched on ORCID iD 0000-0003-0319-9994; OpenAlex author ID A5064032500. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 2 papers · 2026: 1 paper
Papers 6
- Early induction of the Rho-GEF ECT2 drives MEK/ERK oncogenic signaling in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-026-03860-3↗
- A vaccination strategy to prevent coxsackie virus B3-induced development of pancreatic cancer. Co-author DOI 10.1172/jci.insight.192629↗
- Downregulation of Sod2 increases atypical flat lesions and dysplasia to advance pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12943-025-02518-0↗
- Protein kinase D1 - A targetable mediator of pancreatic cancer development. Co-author DOI 10.1016/j.bbamcr.2023.119646↗
- Coxsackievirus and adenovirus receptor expression facilitates enteroviral infections to drive the development of pancreatic cancer. Co-author DOI 10.1038/s41467-024-55043-x↗
- Ym1+ macrophages orchestrate fibrosis, lesion growth, and progression during development of murine pancreatic cancer. Co-author DOI 10.1016/j.isci.2022.104327↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Peter Störz · 6 shared papers, 2022–2026 · strength 1.64
- Paper Protein kinase D1 - A targetable mediator of pancreatic cancer development. DOI 10.1016/j.bbamcr.2023.119646↗
- Paper Downregulation of Sod2 increases atypical flat lesions and dysplasia to advance pancreatic ductal adenocarcinoma. DOI 10.1186/s12943-025-02518-0↗
- Paper Early induction of the Rho-GEF ECT2 drives MEK/ERK oncogenic signaling in pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-026-03860-3↗
- Heike R. Döppler · 4 shared papers, 2022–2025 · strength 0.91
- Paper Downregulation of Sod2 increases atypical flat lesions and dysplasia to advance pancreatic ductal adenocarcinoma. DOI 10.1186/s12943-025-02518-0↗
- Paper A vaccination strategy to prevent coxsackie virus B3-induced development of pancreatic cancer. DOI 10.1172/jci.insight.192629↗
- Paper Ym1+ macrophages orchestrate fibrosis, lesion growth, and progression during development of murine pancreatic cancer. DOI 10.1016/j.isci.2022.104327↗
- Ligia I. Bastea · 4 shared papers, 2022–2025 · strength 0.91
- Paper Downregulation of Sod2 increases atypical flat lesions and dysplasia to advance pancreatic ductal adenocarcinoma. DOI 10.1186/s12943-025-02518-0↗
- Paper A vaccination strategy to prevent coxsackie virus B3-induced development of pancreatic cancer. DOI 10.1172/jci.insight.192629↗
- Paper Ym1+ macrophages orchestrate fibrosis, lesion growth, and progression during development of murine pancreatic cancer. DOI 10.1016/j.isci.2022.104327↗
- Veethika Pandey · 2 shared papers, 2024–2025 · strength 0.44
- Verline Justilien · 1 shared paper, 2026 · strength 0.28
- Nicole R Murray · 1 shared paper, 2026 · strength 0.28
- Dania S. Al-Qasrawi · 1 shared paper, 2026 · strength 0.28
- Geou‐Yarh Liou · 1 shared paper, 2022 · strength 0.19
- E. Aubrey Thompson · 1 shared paper, 2024 · strength 0.18
- Lizhi Zhang · 1 shared paper, 2024 · strength 0.18
- Michael Anthony Hollingsworth · 1 shared paper, 2024 · strength 0.18
- Paul M. Grandgenett · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.